Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

Grounds for refusal include an applicant who has been convicted of a criminal offense in the U.K. or overseas for which they ...

There is no evidence that the NBA drug tested Bronny James after his athletic dunk on Sunday in Summer League action.

While some sites were partially cleaned up, it was back to business as usual within a couple of months — in fact, worse than ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Investing.com -- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) stock surged 10% after the company announced positive topline results from its Phase 2 trial evaluating bivamelagon, an investigational oral m ...

Donald Trump has said that the US will impose a roughly 50 per cent tariff on copper imports, sending prices for the industrial metal soaring and escalating his global trade war. The president said at ...

In a letter addressed to the Health Minister, Dr. Nalinda Jayatissa, the Association of Medical Specialists (AMS) pointed out ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of he ...

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants.

The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts. Today’s piece is by Ana Clara Bobadilla, Colorado State University. (THE CONVERSATION) — ...

The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...